Literature DB >> 15247861

[Encephalopathy and acute renal failure during acyclovir treatment].

A Delluc1, Y Mocquard, P Latour, J-Y Goas.   

Abstract

INTRODUCTION: Adverse neurological and renal effects can occur in patients taking acyclovir. Neurotoxicity of acyclovir results from an accumulation of the antiviral and its metabolites in the bloodstream. This can be observed in the elderly or in patients with chronic renal failure, generally in dialysis patients. Acute renal failure results from intratubular crystallization of acyclovir. OBSERVATION: A 78-year-old right-handed woman was admitted in an emergency setting for aphasia. Analysis of the cerebrospinal fluid was normal, but herpetic meningo-encephalitis was suspected and intravenous treatment was initiated with acyclovir. After the second infusion, the patient began to suffer from visual hallucinations, confusion and acute renal failure. Herpes PCR was negative in the cerebrospinal fluid, and the adverse drug reactions regressed completely after 72 hours.
CONCLUSION: Renal function has to be checked often in patients given acyclovir for appropriate dose titration. Patients recover prompt from the adverse effects at drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247861     DOI: 10.1016/s0035-3787(04)71022-x

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Acute renal injury induced by valacyclovir hydrochloride: A case report.

Authors:  Yanning Zhang; Yuxi Cong; Yan Teng
Journal:  Exp Ther Med       Date:  2016-11-15       Impact factor: 2.447

2.  Oral acyclovir induced acute renal failure.

Authors:  Jian-Biao Meng; Xia Zheng; Gen Zhang; Qiang Fang
Journal:  World J Emerg Med       Date:  2011

3.  Proteomic characterization of acyclovir-induced nephrotoxicity in a mouse model.

Authors:  Hong Lu; Ya-Juan Han; Jia-Dong Xu; Wen-Min Xing; Jie Chen
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.